We strive to provide the highest level of care to every patient and offer the highest level of education to new generations of doctors by continuous success in laboratory and clinical research leading to exciting discoveries.
Blood & Marrow Transplant Program at the University of Illinois Hospital and Health Sciences System is well known throughout the Chicago region for its expertise in blood and marrow transplantation. Treating a wide variety of hematological malignancies and other blood abnormalities, our BMT Program also conducts leading-edge translational research to develop innovative strategies for improving the outcomes of these transplants.
Head & Neck Cancer
In collaboration with otolaryngology, this is a multidisciplinary program including radiation oncology, medical oncologists, neuro radiologists, pathologists, and speech pathologists.
Sickle Cell Disease
The University of Illinois Hospital and Health Sciences System was the first center outside of the NIH to offer to appropriate patients the potentially curative approach of hematopoietic stem cell transplantation. This program is nationally recognized and remains at the cutting edge of patient care and research. transplants.
A new collaboration between the department heads of Medicine and Surgery led to the establishment of a new Breast Cancer Program under the leadership of Dr. Kent Hoskins (Hematology/Oncology). The program has grown into a comprehensive research and clinical unit and in 2015 achieved accreditation by the National Accreditation Program for Breast Centers (NAPBC), part of the American College of Surgeons.
Division of Hematology/ Oncology
840 S Wood St, 820-E CSB, MC 713
Chicago, IL 60612
Outpatient Cancer Center
1801 W. Taylor, 1-E, MC 821
Chicago, IL 60612